These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31618285)
1. Disseminated cutaneous leishmaniasis: A case report. Badaró BA; Diniz LM Rev Soc Bras Med Trop; 2019; 52():e20190349. PubMed ID: 31618285 [No Abstract] [Full Text] [Related]
2. Old-world leishmaniasis of the auricle. Skevas A; Kastanioudakis I; Bai M; Kostoula A Lancet; 1997 Jan; 349(9044):28-9. PubMed ID: 8988123 [No Abstract] [Full Text] [Related]
3. Cutaneous leishmaniasis with boggy induration and simultaneous mucosal disease. Mings S; Beck JC; Davidson C; Ondo AL; Shanler SD; Berman J Am J Trop Med Hyg; 2009 Jan; 80(1):3-5. PubMed ID: 19141829 [TBL] [Abstract][Full Text] [Related]
4. SOD1 plasma level as a biomarker for therapeutic failure in cutaneous leishmaniasis. Khouri R; Santos GS; Soares G; Costa JM; Barral A; Barral-Netto M; Van Weyenbergh J J Infect Dis; 2014 Jul; 210(2):306-10. PubMed ID: 24511100 [TBL] [Abstract][Full Text] [Related]
5. Treatment of cutaneous leishmaniasis: retrospectives and advances for the 21st century. Moskowitz PF; Kurban AK Clin Dermatol; 1999; 17(3):305-15. PubMed ID: 10384870 [No Abstract] [Full Text] [Related]
8. Cutaneous leishmaniasis affecting the face: report of a case. Amin M; Manisali M J Oral Maxillofac Surg; 2000 Sep; 58(9):1066-9. PubMed ID: 10981992 [No Abstract] [Full Text] [Related]
9. Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients. Silva SC; Guimarães LH; Silva JA; Magalhães V; Medina L; Queiroz A; Machado PRL; Schriefer A Acta Trop; 2018 Feb; 178():34-39. PubMed ID: 29042262 [TBL] [Abstract][Full Text] [Related]
10. FLI1 gene influences lesion size and skin test may predict therapeutic response in cutaneous leishmaniasis. da Hora AS; de Almeida LF; do Lago TS; Machado PR; Castellucci LC Mem Inst Oswaldo Cruz; 2020; 115():e190361. PubMed ID: 32130370 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous leishmaniasis in a returning UK traveller. Singh Raghunath R; Yong AS; Igali L; Tan E; Lockwood D Postgrad Med J; 2014 Sep; 90(1067):540-1. PubMed ID: 25053817 [No Abstract] [Full Text] [Related]
12. Oral Pentoxifylline Associated with Pentavalent Antimony: A Randomized Trial for Cutaneous Leishmaniasis. Brito G; Dourado M; Guimarães LH; Meireles E; Schriefer A; de Carvalho EM; Machado PRL Am J Trop Med Hyg; 2017 May; 96(5):1155-1159. PubMed ID: 28500815 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device. Bogenrieder T; Lehn N; Landthaler M; Stolz W Dermatology; 2003; 206(3):269-72. PubMed ID: 12673089 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous leishmaniasis of the lower lip in a United States soldier. Roundy S; Almony J; Zislis T J Oral Maxillofac Surg; 2008 Jul; 66(7):1513-5. PubMed ID: 18571042 [No Abstract] [Full Text] [Related]
17. Refractory cutaneous leishmaniasis in an adolescent: initial manifestation of type 1 diabetes. Atabek ME; Pirgon O; Unal E J Infect; 2006 Oct; 53(4):290-1. PubMed ID: 16466661 [No Abstract] [Full Text] [Related]
18. Cutaneous lupoid leishmaniasis: a case report. Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491 [TBL] [Abstract][Full Text] [Related]
19. Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine. Kumar D; Ramesh V; Verma S; Ramam M; Salotra P Ann Trop Med Parasitol; 2009 Dec; 103(8):727-30. PubMed ID: 20030997 [No Abstract] [Full Text] [Related]
20. Leishmaniasis recidivans in a Palestinian Bedouin child. Al-Jawabreh A; Nasereddin A Skinmed; 2007; 6(5):250-2. PubMed ID: 17786107 [No Abstract] [Full Text] [Related] [Next] [New Search]